Literature DB >> 23962172

Biofilm formation by Aspergillus fumigatus.

Savneet Kaur1, Shweta Singh.   

Abstract

Aspergillus fumigatus is a well adapted, opportunistic fungus that causes a severe and commonly fatal disease, invasive pulmonary aspergillosis (IPA), in highly immunocompromised patients, aspergilloma in patients with lung cavities and allergic bronchopulmonary aspergillosis (ABPA) in hypersensitive individuals. Recent studies have suggested that biofilm formation by A. fumigatus may be one of the most important virulence factors in IPA and aspergilloma. Several fungal constituents may contribute to the formation of biofilm structures on host cells, including cell wall components, secondary metabolites and drug transporters. The biofilm phenotype of the fungus is refractory to most conventional antifungal treatment options. Thus, an in-depth analysis and understanding of A. fumigatus biofilms is necessary to devise newer and better antifungal targets for treating complex A. fumigatus biofilm-associated diseases.

Entities:  

Keywords:  Aspergillus fumigatus; aspergilloma; biofilms; invasive pulmonary aspergillosis

Mesh:

Year:  2014        PMID: 23962172     DOI: 10.3109/13693786.2013.819592

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  53 in total

1.  E-cadherin mediates adhesion of Aspergillus fumigatus to non-small cell lung cancer cells.

Authors:  Tingxiu Yan; Junqing Han; Xiaoming Yu
Journal:  Tumour Biol       Date:  2015-10-15

2.  Seven cases of localized invasive sino-orbital aspergillosis.

Authors:  Hideaki Kawakami; Kiyofumi Mochizuki; Kyoko Ishida; Kiyofumi Ohkusu
Journal:  Jpn J Ophthalmol       Date:  2017-01-17       Impact factor: 2.447

Review 3.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 4.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

5.  Ega3 from the fungal pathogen Aspergillus fumigatus is an endo-α-1,4-galactosaminidase that disrupts microbial biofilms.

Authors:  Natalie C Bamford; François Le Mauff; Adithya S Subramanian; Patrick Yip; Claudia Millán; Yongzhen Zhang; Caitlin Zacharias; Adam Forman; Mark Nitz; Jeroen D C Codée; Isabel Usón; Donald C Sheppard; P Lynne Howell
Journal:  J Biol Chem       Date:  2019-08-15       Impact factor: 5.157

6.  In vitro Paracoccidioides brasiliensis biofilm and gene expression of adhesins and hydrolytic enzymes.

Authors:  Janaina de Cássia Orlandi Sardi; Nayla de Souza Pitangui; Aline Raquel Voltan; Jaqueline Derissi Braz; Marcelo Pelajo Machado; Ana Marisa Fusco Almeida; Maria Jose Soares Mendes Giannini
Journal:  Virulence       Date:  2015       Impact factor: 5.882

7.  Analysis of the Aspergillus fumigatus Biofilm Extracellular Matrix by Solid-State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Courtney Reichhardt; Jose A G Ferreira; Lydia-Marie Joubert; Karl V Clemons; David A Stevens; Lynette Cegelski
Journal:  Eukaryot Cell       Date:  2015-07-10

8.  Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid.

Authors:  Eva Kvasničková; Vít Paulíček; Martina Paldrychová; Richard Ježdík; Olga Maťátková; Jan Masák
Journal:  World J Microbiol Biotechnol       Date:  2016-09-22       Impact factor: 3.312

Review 9.  The Mechanistic Targets of Antifungal Agents: An Overview.

Authors:  Tryphon K Mazu; Barbara A Bricker; Hernan Flores-Rozas; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

10.  Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm.

Authors:  Hasan Nazik; John C Penner; Jose A Ferreira; Janus A J Haagensen; Kevin Cohen; Alfred M Spormann; Marife Martinez; Vicky Chen; Joe L Hsu; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.